PTC Therapeutics, Inc. (PTCT) Net margin 2016–2025
PTC Therapeutics, Inc. (PTCT) net profit margin by fiscal year — reported net income divided by reported revenue.
39.5%FY2025 · since FY2016: -171.8% → 39.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 39.5% | +84.5 pp |
| FY2024 | -45.0% | +21.8 pp |
| FY2023 | -66.8% | +13.2 pp |
| FY2022 | -80.0% | +17.3 pp |
| FY2021 | -97.3% | +17.8 pp |
| FY2020 | -115.1% | -33.1 pp |
| FY2019 | -82.0% | -33.6 pp |
| FY2018 | -48.4% | -7.7 pp |
| FY2017 | -40.6% | +131.2 pp |
| FY2016 | -171.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice